Germany Reviews Pharmacy Regulations Following EU Scrutiny

The German Federal Ministry of Health (BMG) has submitted revised pharmacy regulatory changes to the European Commission for assessment. This development follows the Bundesrat's recent adoption of amendments influencing cross-border mail-order pharmaceutical trade, which directly intersects with European Union law.

In accordance with EU Directive 2015/1535, the draft regulation was formally notified to Brussels in January, initiating a mandatory standstill period. This process ensures that the proposed legislative changes are consistent with EU legal standards and allows the European Commission and other member states to review and raise concerns before national implementation. During this standstill phase, Germany is not permitted to enact the regulation in its final form.

The standstill period was originally set to conclude in mid-April. However, the European Commission fully utilized the allotted timeframe and, shortly before expiration, communicated comprehensive reservations regarding the proposed regulations. As a result, the review period was extended by an additional three months, ending most recently.

One of the key points of contention concerned the regulation's initial requirement that logistics providers involved in pharmaceutical shipments maintain strict temperature controls. The Commission deemed these stipulations excessive, particularly in the context of cross-border commerce. Prior advocacy from logistics companies and mail-order pharmacies in Brussels also contributed to the raised objections.

In response to the feedback from Brussels, the BMG adjusted the proposal. The sections mandating stringent temperature controls for logistics firms were withdrawn, while other parts of the regulation were updated to address practical concerns. The Bundesrat subsequently approved the revised version, now requiring mail-order pharmacies to implement risk-based quality management protocols for packaging, transportation, and delivery. Additionally, specific standards for delivery services must be established within each pharmacy's quality management system.

The Ministry of Health is currently evaluating the Bundesrat's modifications. According to officials, the Ministry must either accept or reject the regulation in its entirety; partial adoption is not possible. It is considered unlikely that the measure will be rejected, as it is closely linked with broader pharmacy reforms, including the Apothekenversorgung-Weiterentwicklungsgesetz (ApoVWG) and associated regulatory changes regarding pharmacy remuneration. These reforms are intended to modernize and finalize the ongoing transformation of pharmacy operations in Germany.

The process highlights the complexities of aligning national healthcare regulations with European legal frameworks, especially in the area of pharmaceutical logistics and mail-order services. Stakeholders across the pharmacy sector, including logistics providers and online pharmacies, are closely monitoring developments, as the outcome may set precedents for future regulatory coordination within the EU single market.